Cyberknife

CyberKnife is a frameless robotic radiosurgery system used for treating benign tumors, malignant tumors and other medical conditions. The system was invented by John R. Adler, a professor of neurosurgery and radiation oncology at Stanford University.

History

The CyberKnife system is a method of delivering radiotherapy, with the intention of targeting treatment more accurately than standard radiotherapy. The idea behind the system was to combine the latest advances in robotics and image guidance technology. The first treatments were performed in 1994.

Design

The CyberKnife system is composed of a compact linear accelerator, which generates high-energy radiation, mounted on a robotic arm. The system uses image guidance software to track and continually adjust treatment for any patient or tumor movement. This continual adjustment is what allows the system to deliver a high dose of radiation with extreme accuracy.

Treatment

The CyberKnife system is used to treat conditions within the body, including tumors within the spine, lung, prostate, liver and pancreas. It can also be used to treat conditions within the head, neck and brain. The system is able to deliver beams of high dose radiation to tumors with extreme accuracy.

Advantages

Unlike traditional surgery, treatment with the CyberKnife system does not require any incisions. The system's extreme precision minimizes the damage to healthy tissues and organs. This precision also allows tumors and other conditions that may be considered inoperable or untreatable by other methods to be treated.

Disadvantages

While the CyberKnife system has many advantages, it also has some disadvantages. These include the fact that it is a relatively new technology and as such, long-term data on its effectiveness and potential side effects is not yet available. Additionally, not all tumors and conditions can be treated with the CyberKnife system.

See also

• Radiosurgery
• Radiation therapy
• Linear accelerator

Cyberknife Resources
Latest articles Most recent articles Ongoing trials	Wikipedia